Eurofins Genomics and tilibit nanosystems launch a global distribution agreement.
Eurofins Genomics, the international market leader in genomic services, has signed a global distribution agreement for DNA Origami products with tilibit nanosystems, specialists in 3D origami shapes and considered the leader of custom engineered DNA based nanodevices.
DNA origami is a technique that allows the construction of objects at the nanometer scale using DNA double-helices as building blocks through sequence-programmed self-assembly. Tilibit nanosystems is a pioneer with leading expertise to design and build nanodevices with a variety of chemical functionalities. This agreement continues to build on a long standing relationship between Eurofins Genomics as a provider for DNA oligonucleotides and tilibit, as the manufacturer of scaffold DNA and experts in DNA origami. The collaboration aims to provide all compounds for nanodevices to a worldwide research community including oligonucleotides, scaffold DNA and accessories.
Fig.: Exemplary objects that can be realised with DNA origami.
“DNA origami is an exciting and highly innovative technology with future applications in various fields, such as clinical therapy, nanorobotics and research therefore, Eurofins Genomics is extremely pleased to support the supply and global reach of DNA origami products,” says Dr. Peter Persigehl, General Manager Eurofins Genomics Europe.
“Every field of research needs materials, and so does DNA nanotechnology. Until recently, some of those specialised materials have only been available to select research groups so this distribution agreement solves the availability problem. Together, Eurofins Genomics and tilibit provide high-quality hard-to-find materials in the right form, in suitable quantities, and at highly competitive prices which will help DNA nanotechnology to grow and become a mature engineering discipline,“ says Prof. Dr. Hendrik Dietz, CEO of tilibit nanosystems GmbH.